Imatinib Recruiting Phase 2 Trials for Colonic Neoplasms Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02685046Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy